Innovative Journal of Pediatrics
The Scientific Journal of Growth & Development Research Center
Scopus by Title (Ref)
1. Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Hospitalizations in Preterm Infants Born to 29 0/7 to 31 6/7 Weeks of Gestational Age
- Zamur E. , et al.
2. Effectiveness and Safety of Palivizumab for the Prevention of Serious Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus: A Systematic Review
- Gonzales T. , et al.
3. Risk Factors for Respiratory Syncytial Virus Infections in Moderate/Late Premature Infants in Turkey: A Prospective Multicenter Epidemiological Study
- Ozkan H. , et al.
4. Assessing the risk of early unplanned rehospitalisation in preterm babies: EPIPAGE 2 study
- Reed R.A. , et al.
5. Prognosis of bronchopulmonary dysplasia in preterm infants: A follow-up during infancy
- Wei H.L. , et al.
6. Comment on Pacheco-González et al
- Zaidi M. , et al.
7. Survey of hospitalization for respiratory syncytial virus in Nagano, Japan
- Yanagisawa T. , et al.
8. Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis
- Cetinkaya M. , et al.